← All guides
Growth Hormone

CJC-1295 with DAC 5 mg

Long-Acting Growth Hormone Releasing Hormone Analogue — A Plain-Language Guide

CJC-1295 with DAC is a modified GHRH analogue. The DAC (Drug Affinity Complex) extension dramatically extends its half-life — from hours to about 7–10 days. This means fewer injections with sustained GH stimulation.

What it does

  • Stimulates pituitary to release growth hormone
  • Increases IGF-1 levels (muscle and tissue repair)
  • Supports muscle growth and recovery
  • Promotes fat loss over time
  • Improves sleep quality
  • Supports anti-aging and cellular repair

CJC with DAC vs CJC with Ipamorelin

FeatureCJC + IpamorelinCJC + DAC
Half-life~30 min~7–10 days
DosingDaily (nightly)2x per week
GH patternPulsatile (natural)Sustained elevation
Best forSleep + recoveryBody comp + longevity

Why people use it

  • Muscle growth and recovery
  • Fat loss (especially body recomposition)
  • Anti-aging protocols
  • Sleep improvement
  • Fewer injections than daily peptides

What people notice

  • Improved body composition over weeks
  • Better recovery from training
  • Improved sleep quality
  • Gradual lean muscle improvement

Cycle length

PhaseDuration
On-Cycle8–16 weeks
Off-Cycle4–8 weeks
TaperingNot required

Why cycle

Cycling prevents receptor desensitization and allows IGF-1 levels to return to baseline.

Reconstitution

Reconstitution instructions

Add 100 units (1 mL) of bacteriostatic water to the 5 mg vial. Inject water slowly down the side of the vial. Gently swirl — do not shake. Store in refrigerator after mixing.

Vial SizeBAC Water AddedConcentration
5 mg100 units (1 mL)0.05 mg per unit

Dosing

Dosing schedule

ItemInstruction
Draw Amount20 units (0.20 mL)
Volume0.20 mL
FrequencyTwice per week
TimingFasted state, before bed
Injection TypeSubcutaneous

Other guides

Peptide research disclaimer

This document is provided in a reference-style format for research-use-only peptide products. The preparer of this handout is not a licensed medical physician, and all information contained herein reflects personal opinion and generalized reference formatting only. Any dosing, mixing, reconstitution, or scheduling information included in this document is not medical advice, is not intended to diagnose, treat, cure, or prevent any disease, and should not be interpreted as clinical guidance.

All peptides and related compounds referenced in this document are understood to be for laboratory or research purposes only and not intended for human consumption. By using or sharing this document, the reader accepts full responsibility for any interpretation, handling, storage, reconstitution, or use of the products referenced, and the preparer disclaims liability for any misuse, unauthorized application, or consequences arising from such use.